|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/385 | |
| A61K 47/54 | |||
| A61K 47/64 | |||
| A61P 31/00 | |||
| A61K 47/61 | |||
| C07K 7/62 |
| (11) | Number of the document | 3512544 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17771531.5 |
| Date of filing the European patent application | 2017-09-13 | |
| (97) | Date of publication of the European application | 2019-07-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2017/052699 |
| Date | 2017-09-13 |
| (87) | Number | WO 2018/051085 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201615560 | 2016-09-13 | GB | |
| 201707076 | 2017-05-04 | GB |
| (72) |
GLOSSOP, Melanie, GB
WATSON, Christine, GB
WESTBY, Michael, GB
|
| (73) |
Centauri Therapeutics Limited,
1st Floor Thavies Inn House 3-4 Holborn Circus, London EC1N 2HA,
GB
|
| (54) | PEPTIDE COMPOUNDS AND THERAPEUTIC USES THEREOF |
| PEPTIDE COMPOUNDS AND THERAPEUTIC USES THEREOF |